Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-11-08
2005-11-08
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S118000, C544S262000, C540S575000, C514S211080, C514S262100, C548S371700
Reexamination Certificate
active
06962915
ABSTRACT:
Compounds having the formula (I),and pharmaceutically acceptable salts or prodrugs thereof, are useful as kinase inhibitors, wherein Y is —C(═O)NR1—, —NR1C(═O)—, —NR1C(═O)NR1—, —NR1SO2—, —SO2NR1—, —C(═O)—, —OC(═O)—, or —CO2—; B is alkyl, substituted alkyl, alkenyl, substituted alkenyl, hydroxy, alkoxy, aryl, cycloalkyl, heteroaryl, and heterocyclo; or when Y is —C(═O)NR1—, B also may be selected from —C(═O)R8, —C(═O)NR8R9, and —CO2R8; R1is hydrogen, C1-4alkyl, or substituted C1-4alkyl; R2is hydrogen or C1-4alkyl; R3is hydrogen, methyl, perfluoromethyl, hydroxy, methoxy, halogen, cyano, NH2, or NH(CH3); and R4, R5, R6, R7, R8, and R9are as defined in the specification.
REFERENCES:
patent: 5593997 (1997-01-01), Dow et al.
patent: 5723608 (1998-03-01), Yuan
patent: 6147080 (2000-11-01), Bemis et al.
patent: 6277989 (2001-08-01), Chakravarty et al.
patent: 6548509 (2003-04-01), Yuan
patent: 6670357 (2003-12-01), Leftheris et al.
patent: 2003/0232831 (2003-12-01), Dyckman et al.
patent: 2004/0082582 (2004-04-01), Dyckman et al.
patent: WO94/13677 (1994-06-01), None
patent: WO99/15164 (1999-04-01), None
patent: WO 00/56738 (2000-09-01), None
patent: WO 00/71129 (2000-11-01), None
patent: WO 01/14378 (2001-03-01), None
patent: WO 01/27089 (2001-04-01), None
patent: WO 01/34605 (2001-05-01), None
patent: WO02/12226 (2002-02-01), None
patent: WO02/12227 (2002-02-01), None
patent: WO02/12228 (2002-02-01), None
patent: WO02/16348 (2002-02-01), None
Figure 13-4: Cytokines http://www.whfreeman.com/immunology/CH13/cytokines.htm Downloaded from the Internet Jul. 15, 2003.
Boehm, Expert Opinion Therapeutic Patents (2000) 10(1) 25.
Henry et al., Drug. Fut., vol. 24, pp. 1345-1354 (1999).
Rankin et al., Br. J. Rheumatol., vol. 34, pp. 334-342 (1995).
Moreland et al., Ann. Intern. Med., vol. 130, pp. 478-486 (1999).
Das Jagabandhu
Leftheris Katerina
Liu Chunjian
Moquin Robert V.
Berch Mark L.
Bristol--Myers Squibb Company
Korsen Elliott
Wang Joseph C.
Winslow Anastasia P.
LandOfFree
Pyrazolo-pyrimidine aniline compounds useful as kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolo-pyrimidine aniline compounds useful as kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolo-pyrimidine aniline compounds useful as kinase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3489911